European Economic AreaBiocidal Products Regulation (BPR)

EU Commission Extends Biobor JF Use For Aircraft Safety

The European Commission has approved the Polish Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products to extend the use of Biobor JF, a crucial biocidal product, until 13 March 2025. This decision, detailed in Commission Implementing Decision (EU) 2023/2634 dated 27 November 2023, comes as a significant step in ensuring air transport safety.

Published in January 2024. Dates, deadlines and stages may have changed since.

Dr Steven Brennan

2 min readAI-drafted, expert reviewed

Plane in the sky

The European Commission has approved the Polish Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products to extend the use of Biobor JF, a crucial biocidal product, until 13 March 2025. This decision, detailed in Commission Implementing Decision (EU) 2023/2634 dated 27 November 2023, comes as a significant step in ensuring air transport safety.

Background And Necessity

In March 2023, Poland authorised the use of Biobor JF for professional users to treat microbial contamination in aircraft fuel tanks and systems. This contamination, primarily by bacteria, mould, and yeast, can severely impact aircraft engine performance and safety. Given the absence of viable alternatives and the critical role of Biobor JF in maintaining operational safety, the extension was deemed necessary.

Biobor JF contains unique active substances, not yet fully evaluated under EU biocidal regulations. However, its effectiveness in controlling microbial contamination has been unparalleled, especially since the withdrawal of alternative products like Kathon™ FP 1.5 in 2020 due to safety concerns.

The manufacturer of Biobor JF is working towards EU approval, with an application expected in early 2024. This process, while essential for long-term authorization, is time-consuming, necessitating the current extension.

Safety And Operational Concerns

With no other biocidal product meeting the required safety and efficiency standards, and mechanical treatments posing risks, the Commission recognized the urgent need for this extension. The lack of effective microbial control in aircraft fuel systems poses a significant risk to air transport safety.

Implications And Actions

This decision underscores the critical balance between regulatory compliance and operational safety in the aviation sector. Stakeholders are advised to monitor developments closely and prepare for future regulatory changes while prioritising safety.

The European Commission’s decision is a proactive measure ensuring the safety of air transport, reflecting the complexity of balancing regulatory standards with practical safety needs in the aviation industry.

Dr Steven Brennan

CEO and co-founder of Foresight, and a co-opted member of ECHA's Committee for Socio-economic Analysis. He holds a PhD in chemical engineering.

More from Dr Steven Brennan

Join 3,500+ professionals staying ahead

Foresight Weekly brings the week's regulatory changes across chemicals, product safety, sustainability, ESG and EHS into one email.

Free. Unsubscribe at any time.

Read by professionals at

  • Boeing
  • AstraZeneca
  • Siemens
  • PepsiCo
  • SpaceX